tiprankstipranks
Trending News
More News >
Adhera Therapeutics Inc (ATRX)
:ATRX
US Market
Advertisement

Adhera Therapeutics (ATRX) Income Statement

Compare
13 Followers

Adhera Therapeutics Income Statement

Last quarter (Q3 2023), Adhera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Adhera Therapeutics's net income was $-3.54M. See Adhera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 252.00K$ 76.19K
Gross Profit
$ 0.00$ 0.00$ 0.00$ -157.00K$ -382.52K
Operating Expenses
$ 1.62M$ 674.00K$ 2.04M$ 11.16M$ 10.24M
Depreciation and Amortization
$ 1.62M$ 674.00K$ 82.00K$ 82.00K$ 332.99K
EBITDA
$ -1.62M$ -674.00K$ -1.99M$ -11.23M$ -16.27M
Operating Income
$ -1.62M$ -674.00K$ -2.04M$ -11.32M$ -15.79M
Other Income/Expenses
$ -496.00K$ -5.68M$ -1.73M$ -662.00K$ -959.96K
Pretax Income
$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Net Income
$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Per Share Metrics
Basic EPS
$ -1.18$ -12.84$ -9.80$ -24.80$ -30.92
Diluted EPS
$ -1.18$ -12.84$ -9.80$ -24.80$ -30.92
Weighted Average Shares Outstanding
2.31M 650.18K 543.83K 542.04K 541.94K
Weighted Average Shares Outstanding (Diluted)
2.31M 650.18K 543.83K 542.04K 541.94K
Currency in USD

Adhera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis